Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 28

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Antimicrobial peptides: A novel and promising arsenal against methicillin-resistant Staphylococcus aureus (MRSA) infections

Odunitan, Tope T., Oyaronbi, Adegboye O., Adebayo, Fakuade A., Adekoyeni, Paul A., Apanisile, Boluwatife T., Oladunni, Tolu D., Saibu, Oluwatosin A. · 2024 · Pharmaceutical Science Advances

Abstract

Antimicrobial peptides (AMPs), with their precise targeting mechanisms and innate modifiability, have emerged as promising therapeutic agents. By selectively interrupting bacterial processes and boosting innate immunological responses, AMPs offer a multifaceted strategy. Modern biotechnological and bioinformatics advancements have enabled the refinement of AMPs for improved efficacy. This comprehensive review delves into the intricate facets of MRSA pathogenicity, determinants of resistance, foundational tenets of peptide-based therapeutics, and recent scientific breakthroughs. A comprehensive analysis of the current research landscape, clinical implications, and persistent challenges underscores the potential of precisely tailored peptides as formidable weapons for counteracting the enduring threat of MRSA infections.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.pscia.2023.100034

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 150

  1. Lowy, 1998, Staphylococcus aureus infections, N. Engl. J. Med., 339, 520, 10.1056/NEJM199808203390806 · DOI · Paper page
  2. F.A. Waldvogel, Staphylococcus aureus. In: G.L. Mandell, R.G. Douglas & J.E. Bennett (ed.), Principles and Practices of Infectious Disease, third ed. Churchill Livingstone, Philadelphia, Pennsylvania, USA, 121(8) 1754-1777..
  3. De Oliveira, 2020, Antimicrobial resistance in ESKAPE pathogens, Clin. Microbiol. Rev., 33, 10.1128/CMR.00181-19 · DOI · Paper page
  4. Murray, 2022, Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis, Lancet, 399, 629, 10.1016/S0140-6736(21)02724-0 · DOI · Paper page
  5. Hryniewicz, Epidemiology of MRSA, Infection 27 (Suppl 2) (1999) S13–S16, https://doi.org/10.1007/BF02561663. · DOI · Paper page
  6. Mlynarczyk, 2009, Mechanisms of the resistance and tolerance to beta-lactam and glycopeptide antibiotics in pathogenic gram-positive cocci, Mini Rev. Med. Chem., 9, 1527, 10.2174/138955709790361557 · DOI · Paper page
  7. Huang, 2010, Alpha-helical cationic antimicrobial peptides: relationships of structure and function, Protein Cell, 1, 143, 10.1007/s13238-010-0004-3 · DOI · Paper page
  8. Lei, 2019, The antimicrobial peptides and their potential clinical applications, Am. J. Transl. Res., 11, 3919
  9. Mallapragada, 2017, Antimicrobial peptides: the miraculous biological molecules, J. Indian Soc. Periodontol., 21, 434, 10.4103/jisp.jisp_325_16 · doi:10.4103/jisp.jisp_325_16
  10. Florin, 2017, An antimicrobial peptide that inhibits translation by trapping release factors on the ribosome, Nat. Struct. Mol. Biol., 24, 752, 10.1038/nsmb.3439 · DOI · Paper page
  11. Xuan, 2023, Antimicrobial peptides for combating drug-resistant bacterial infections, Drug Resist. Updates, 68, 100954, 10.1016/j.drup.2023.100954 · DOI · Paper page
  12. Lei, 2019, The antimicrobial peptides and their potential clinical applications, Am. J. Transl. Res., 11, 3919
  13. Jenssen, 2006, Peptide antimicrobial agents, Clin. Microbiol. Rev., 19, 491, 10.1128/CMR.00056-05 · DOI · Paper page
  14. Zhang, 2016, Antimicrobial peptides, Curr. Biol., 26, 14, 10.1016/j.cub.2015.11.017 · DOI · Paper page
  15. Pasupuleti, 2012, Antimicrobial peptides: key components of the innate immune system, Crit. Rev. Biotechnol., 32, 143, 10.3109/07388551.2011.594423 · DOI · Paper page
  16. Haney, 2017, Antimicrobial peptides: an introduction, Methods Mol. Biol., 1548, 3, 10.1007/978-1-4939-6737-7_1 · DOI · Paper page
  17. Boparai, 2020, Mini review on antimicrobial peptide, sources, mechanism and recent applications, Protein Pept. Lett., 27, 4, 10.2174/18755305MTAwENDE80 · DOI · Paper page
  18. Dennison, 2018, An atlas of anionic antimicrobial peptides from amphibians, Curr. Protein Pept. Sci., 19, 823, 10.2174/1389203719666180226155035 · DOI
  19. Teixeira, 2012, Role of lipids in the interaction of antimicrobial peptides with membranes, Prog. Lipid Res., 51, 149, 10.1016/j.plipres.2011.12.005 · DOI · Paper page
  20. Gennaro, 2000, Structural features and biological activities of the cathelicidin-derived antimicrobial peptides, Biopolymers, 55, 31, 10.1002/1097-0282(2000)55:1<31::AID-BIP40>3.0.CO;2-9 · DOI · Paper page
  21. Harris, 2009, Anionic antimicrobial peptides from eukaryotic organisms, Curr. Protein Pept. Sci., 10, 585, 10.2174/138920309789630589 · DOI · Paper page
  22. Lakshmaiah Narayana, 2015, Antimicrobial peptides: possible anti-infective agents, Peptides, 72, 88, 10.1016/j.peptides.2015.05.012 · DOI · Paper page
  23. Jeżowska-Bojczuk, 2018, Peptides having antimicrobial activity and their complexes with transition metal ions, Eur. J. Med. Chem., 143, 997, 10.1016/j.ejmech.2017.11.086 · DOI
  24. Tasiemski, 2004, Molecular characterization of two novel antibacterial peptides inducible upon bacterial challenge in an annelid, the leech Theromyzon tessulatum, J. Biol. Chem., 279, 30973, 10.1074/jbc.M312156200 · DOI
  25. Jiang, 2014, Preparation and identification of peptides and their zinc complexes with antimicrobial activities from silver carp (Hypophthalmichthys molitrix) protein hydrolysates, Food Res. Int., 64, 91, 10.1016/j.foodres.2014.06.008 · DOI
  26. Rathinakumar, 2010, High-throughput discovery of broad-spectrum peptide antibiotics, Faseb. J., 24, 3232, 10.1096/fj.10-157040 · DOI
  27. Bahar, 2013, Antimicrobial peptides, Pharmaceuticals, 6, 1543, 10.3390/ph6121543 · DOI · Paper page
  28. Chen, 2007, Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides, Antimicrob, Agents Chemother, 51, 1398, 10.1128/AAC.00925-06 · DOI · Paper page
  29. Som, 2008, Synthetic mimics of antimicrobial peptides, Peptide Sci, 90, 83, 10.1002/bip.20970 · DOI
  30. Passioura, 2014, Selection-based discovery of druglike macrocyclic peptides, Annu. Rev. Biochem., 83, 727, 10.1146/annurev-biochem-060713-035456 · DOI · Paper page
  31. Vagner, 2008, Peptidomimetics, a synthetic tool of drug discovery, Curr. Opin. Chem. Biol., 12, 292, 10.1016/j.cbpa.2008.03.009 · DOI · Paper page
  32. N. Malanovic, L. Marx, S.E. Blondelle, G. Pabst, E.F. Semeraro, Experimental concepts for linking the biological activities of antimicrobial peptides to their molecular modes of action, Biochim. Biophys. Acta, Biomembr. 1862 · DOI
  33. (8) (2020) 183275, https://doi.org/10.1016/j.bbamem.2020.183275. · DOI
  34. R. Santos, D. Ruza, E. Cunha, L. Tavares, M. Oliveira, Diabetic foot infections: application of a nisin-biogel to complement the activity of conventional antibiotics and antiseptics against Staphylococcus aureus biofilms, PLoS One 14 (7) (2019) e0220000, https://doi.org/10.1371/journal.pone.0220000. · DOI
  35. Williamson, 2017, Current and emerging topical antibacterials and antiseptics: agents, action, and resistance patterns, Clin. Microbiol. Rev., 30, 827, 10.1128/CMR.00112-16 · DOI · Paper page
  36. Fjell, 2012, Designing antimicrobial peptides: form follows function, Nat. Rev. Drug Discov., 11, 37, 10.1038/nrd3591 · DOI · Paper page
  37. Shurko, 2018, Evaluation of LL-37 antimicrobial peptide derivatives alone and in combination with vancomycin against S. aureus, J. Antibiot., 71, 971, 10.1038/s41429-018-0090-7 · DOI
  38. Thapa, 2020, Topical antimicrobial peptide formulations for wound healing: current developments and future prospects, Acta Biomater, 103, 52, 10.1016/j.actbio.2019.12.025 · DOI · Paper page
  39. Hakur, 2022, In pursuit of next-generation therapeutics: antimicrobial peptides against superbugs, their sources, mechanism of action, nanotechnology-based delivery, and clinical applications, Int. J. Biol. Macromol., 218
  40. K.E. Ridyard, J. Overhage, The potential of human peptide LL-37 as an antimicrobial and anti-biofilm agent, Antibiotics 10 (6) (2021) 650, https://doi.org/10.3390/antibiotics10060650. · DOI · Paper page
  41. Sim, 2013, Multiple site surveillance cultures as a predictor of methicillin-resistant Staphylococcus aureus infections, Infect. Control Hosp. Epidemiol., 34, 818, 10.1086/671273 · DOI
  42. D.J. Diekema, M.A. Pfaller, F.J. Schmitz, J. Smayevsky, J. Bell, R.N. Jones, M. Beach, Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999, Clin. Infect. Dis. 32 (Suppl. 2) (2001) S114–S132, https://doi.org/10.1086/320184. · DOI · Paper page
  43. Enright, 2000, Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus, J. Clin. Microbiol., 38, 1008, 10.1128/JCM.38.3.1008-1015.2000 · DOI · Paper page
  44. M. Emonts, et al., Host polymorphisms in interleukin 4, complement factor H, and C-reactive protein associated with nasal carriage of Staphylococcus aureus and occurrence of boils, J. Infect. Dis. 197 (9) (2008) 1244–1253, https://doi.org/10.1086/533501. · DOI
  45. C. Weidenmaie, J.F. Kokai-Kun, E. Kulauzovic, T. Kohler, G. Thumm, H. Stoll, F. Göt, A. Peschel, Differential roles of sortase-anchored surface proteins and wall teichoic acid in Staphylococcus aureus nasal colonization, Int. J. Med. Microbiol. 298 (5–6) (2008) 505–513, https://doi.org/10.1016/j.ijmm.2007.11.006. · DOI
  46. H.F. Wertheim, E. Walsh, R. Choudhurry, D.C. Melles, H.A.M. Boelens, H. Miajlovic, H.A. Verbrugh, T. Foster, A. van Belkum, Key role for clumping factor B in Staphylococcus aureus nasal colonization of humans, PLoS Med. 5 (1) (2008) e17, https://doi.org/10.1371/journal.pmed.0050017. · DOI · Paper page
  47. O’Brien, 2002, Staphylococcus aureus clumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: implications for nasal colonization, Cell Microbiol, 4, 759, 10.1046/j.1462-5822.2002.00231.x · DOI · Paper page
  48. S. Boyle-Vavra, X. Li, T. Alam, T.D. Read, J. Sieth, C. Cywes-Bentley, G. Dobbins, USA300 and USA500 clonal lineages of Staphylococcus aureus do not produce a capsular polysaccharide due to conserved mutations in the cap5 locus, mBio 6 (2) (2015) e02585-14, https://doi.org/10.1128/mbio.02585-14. · DOI
  49. Spaan, 2017, Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors, Nat. Rev. Microbiol., 15, 435, 10.1038/nrmicro.2017.27 · DOI · Paper page
  50. Kluytmans, 1995, Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery, J. Infect. Dis., 171, 216, 10.1093/infdis/171.1.216 · DOI · Paper page
  51. Foster, 2014, Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus, Nat. Rev. Microbiol., 12, 49, 10.1038/nrmicro3161 · DOI · Paper page
  52. Cheng, 2011, A play in four acts: Staphylococcus aureus abscess formation, Trends Microbiol, 19, 225, 10.1016/j.tim.2011.01.007 · DOI · Paper page
  53. Laarman, 2010, Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications, J. Mol. Med., 88, 115, 10.1007/s00109-009-0572-y · DOI
  54. K.Y. Le, M. Otto, Quorum-sensing regulation in staphylococci-an overview, Front. Microbiol. 6 (2015) 1174, https://doi.org/10.3389/fmicb.2015.01174. · DOI · Paper page
  55. Cheung, 2011, Role of the accessory gene regulator agr in community-associated methicillin-resistant Staphylococcus aureus pathogenesis, Infect. Immun., 79, 1927, 10.1128/IAI.00046-11 · DOI · Paper page
  56. Crisostomo, 2001, The evolution of methicillin resistance in Staphylococcus aureus: similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant isolates and contemporary epidemic clones, Proc. Natl. Acad. Sci. U.S.A., 98, 9865, 10.1073/pnas.161272898 · DOI · Paper page
  57. 2009, on the Classification of Staphylococcal Cassette Chromosome Elements (IWG-SCC), Classification of staphylococcal cassette chromosome mec (SCCmec): guidelines for reporting novel SCCmec elements, Antimicrob. Agents Chemother., 53, 4961, 10.1128/AAC.00579-09 · DOI · Paper page
  58. Bal, 2016, Genomic insights into the emergence and spread of international clones of healthcare-, community- and livestock-associated meticillin-resistant Staphylococcus aureus: blurring of the traditional definitions, J. Glob. Antimicrob. Resist, 6, 95, 10.1016/j.jgar.2016.04.004 · DOI
  59. Hartman, 1984, Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus, J. Bacteriol., 158, 513, 10.1128/jb.158.2.513-516.1984 · DOI · Paper page
  60. L. Garcia-Alvarez, et al., Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study, Lancet Infect. Dis. 11 (8) (2011) 595–603, https://doi.org/10.1016/S1473-3099(11)70126-8. · DOI · Paper page
  61. Becker, 2018, Plasmid-encoded transferable mecB-mediated methicillin resistance in Staphylococcus aureus, Emerg. Infect. Dis., 24, 242, 10.3201/eid2402.171074 · DOI · Paper page
  62. Hancock, 2006, Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies, Nat. Biotechnol., 24, 1551, 10.1038/nbt1267 · DOI · Paper page
  63. Peschel, 2006, The co-evolution of host cationic antimicrobial peptides and microbial resistance, Nat. Rev. Microbiol., 4, 529, 10.1038/nrmicro1441 · DOI · Paper page
  64. Nguyen, 2011, The expanding scope of antimicrobial peptide structures and their modes of action, Trends Biotechnol, 29, 464, 10.1016/j.tibtech.2011.05.001 · DOI · Paper page
  65. Jenssen, 2006, Peptide antimicrobial agents, Clin. Microbiol. Rev., 19, 491, 10.1128/CMR.00056-05 · DOI · Paper page
  66. Endo, 1997, Fungicidal action of aureobasidin A, a cyclic depsipeptide antifungal antibiotic, against Saccharomyces cerevisiae, Antimicrob. Agents Chemother., 41, 672, 10.1128/AAC.41.3.672 · DOI
  67. Hale, 2007, Alternative mechanisms of action of cationic antimicrobial peptides on bacteria, Expert Rev. Anti InfectTher., 5, 951, 10.1586/14787210.5.6.951 · DOI · Paper page
  68. Czub, 2006, Comparative molecular dynamics study of lipid membranes containing cholesterol and ergosterol, Biophys. J., 90, 2368, 10.1529/biophysj.105.072801 · DOI · Paper page
  69. Levitz, 1986, In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages, J. Infect. Dis., 154, 483, 10.1093/infdis/154.3.483 · DOI · Paper page
  70. van der Weerden, 2010, Permeabilization of fungal hyphae by the plant defensinNaD1 occurs through a cell wall-dependent process, J. Biol. Chem., 285, 37513, 10.1074/jbc.M110.134882 · DOI · Paper page
  71. Cavassin, 2021, Sixty years of amphotericin B : an overview of the main antifungal agent used to treat invasive fungal infections, Infect. Dis. Ther., 10, 115, 10.1007/s40121-020-00382-7 · DOI · Paper page
  72. De Cesare, 2020, Antimicrobial peptides: a new frontier in antifungal therapy, mBio, 11, 1
  73. Yasir, 2018, Action of antimicrobial peptides against bacterial biofilms, Materials, 11, 2468, 10.3390/ma11122468 · DOI · Paper page
  74. Martinez, 2019, Synergistic and antibiofilm activity of the antimicrobial peptide P5 against carbapenem-resistant Pseudomonas aeruginosa, Biochim. Biophys. Acta Biomembr., 1861, 1329, 10.1016/j.bbamem.2019.05.008 · DOI
  75. Goldberg, 2013, Sensitization of gram-negative bacteria by targeting the membrane potential, Faseb. J., 27, 3818, 10.1096/fj.13-227942 · DOI
  76. Marks, 2012, The human milk protein-lipid complex HAMLET sensitizes bacterial pathogens to traditional antimicrobial agents, PLoS One, 7, 10.1371/journal.pone.0043514 · DOI
  77. Nicolas, 2009, Multifunctional host defense peptides: intracellular-targeting antimicrobial peptides, FEBS J, 276, 6483, 10.1111/j.1742-4658.2009.07359.x · DOI · Paper page
  78. Schneider, 2010, Plectasin, a fungal defensin, targets the bacterial cell wall precursor lipid II, Science, 328, 1168, 10.1126/science.1185723 · DOI · Paper page
  79. Hasper, 2006, An alternative bactericidal mechanism of action for antibiotic peptides that target lipid II, Science, 313, 1636, 10.1126/science.1129818 · DOI · Paper page
  80. Boman, 1993, Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine, Infect. Immun., 61, 2978, 10.1128/iai.61.7.2978-2984.1993 · DOI · Paper page
  81. Patrzykat, 2002, Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli, Antimicrob, Agents Chemother, 46, 605, 10.1128/AAC.46.3.605-614.2002 · DOI · Paper page
  82. Subbalakshmi, 1998, Mechanism of antimicrobial action of indolicidin, FEMS Microbiol. Lett., 160, 91, 10.1111/j.1574-6968.1998.tb12896.x · doi:10.1111/j.1574-6968.1998.tb12896.x · Paper page
  83. Nan, 2009, Investigating the effect of positive charge and hydrophobicity on the cell selectivity, mechanism of action and anti- inflammatory activity of a Trp-rich antimicrobial peptide indolicidin, FEMS Microbiol. Lett., 292, 134, 10.1111/j.1574-6968.2008.01484.x · DOI
  84. Yang, 2001, Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37), J. Leukoc. Biol., 69, 691, 10.1189/jlb.69.5.691 · DOI · Paper page
  85. Niyonsaba, 2002, A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis, Immunol, 106, 20, 10.1046/j.1365-2567.2002.01398.x · DOI · Paper page
  86. Tjabringa, 2006, Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors, Int. Arch. Allergy Immunol., 140, 103, 10.1159/000092305 · DOI · Paper page
  87. Mookherjee, 2009, Intracellular receptor for human host defense peptide LL-37 in monocytes, J. Immunol., 183, 2688, 10.4049/jimmunol.0802586 · DOI · Paper page
  88. Montreekachon, 2011, Involvement of P2X (7) purinergic receptor and MEK1/2 in interleukin-8 up-regulation by LL-37 in human gingival fibroblasts, J. Periodontal. Res., 46, 327, 10.1111/j.1600-0765.2011.01346.x · DOI
  89. Cavaillon, 2003, Cytokine cascade in sepsis, Scand. J. Infect. Dis., 35, 535, 10.1080/00365540310015935 · DOI · Paper page
  90. Zisman, 1997, MCP-1 protects mice in lethal endotoxemia, J. Clin. Investig., 99, 2832, 10.1172/JCI119475 · DOI · Paper page
  91. Bommineni, 2010, A fowlicidin-1 analog protects mice from lethal infections induced by methicillin-resistant Staphylococcus aureus, Peptides, 31, 1225, 10.1016/j.peptides.2010.03.037 · DOI
  92. van der Does, 2010, Antimicrobial peptide hLF1-11 directs granulocyte-macrophage colony-stimulating factor- driven monocyte differentiation toward macrophages with enhanced recognition and clearance of pathogens, Antimicrob. Agents Ch., 54, 811, 10.1128/AAC.00652-09 · DOI
  93. Luo, 2021, Mechanism of antimicrobial peptides: antimicrobial, antiinflammatory and antibiofilm activities, Int. J. Mol. Sci., 22, 11401, 10.3390/ijms222111401 · DOI · Paper page
  94. Mataraci, 2012, In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms, Antimicrob. Agents Chemother., 56, 6366, 10.1128/AAC.01180-12 · DOI
  95. Waters, 2005, Quorum sensing: cell-to-cell communication in bacteria, Annu. Rev. Cell Dev. Biol., 21, 319, 10.1146/annurev.cellbio.21.012704.131001 · DOI · Paper page
  96. Orlando, 2008, BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection, Peptides, 29, 1118, 10.1016/j.peptides.2008.03.005 · DOI
  97. Balaban, 2004, A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci, Antimicrob, Agents Chemother, 48, 2544, 10.1128/AAC.48.7.2544-2550.2004 · DOI
  98. Ganz, 2003, Defensins: antimicrobial peptides of innate immunity, Nat. Rev. Immunol., 3, 710, 10.1038/nri1180 · DOI · Paper page
  99. Scudiero, 2015, Design and activity of a cyclic mini-beta-defensin analog: a novel antimicrobial tool, Int. J. Nanomed., 10, 6523
  100. Dathe, 2004, Cyclization increases the antimicrobial activity and selectivity of arginine- and tryptophan-containing hexapeptides, Biochemistry, 43, 9140, 10.1021/bi035948v · DOI · Paper page
  101. Costa, 2019, Clinical application of AMPs, Adv. Exp. Med. Biol., 1117, 281, 10.1007/978-981-13-3588-4_15 · DOI
  102. Usmani, 2017, THPdb: Database of FDA-approved peptide and protein therapeutics, PLoS One, 12, 10.1371/journal.pone.0181748 · DOI · Paper page
  103. Cheneval, 2014, Fmoc-based synthesis of disulfide-rich cyclic peptides, J. Org. Chem., 79, 5538, 10.1021/jo500699m · DOI
  104. Falanga, 2017, Cyclic peptides as novel therapeutic microbicides: engineering of human defensin mimetics, Molecules, 22, 10.3390/molecules22071217 · DOI
  105. Monaim, 2018, Teixobactin as a scaffold for unlimited new antimicrobial peptides: SAR study, Bioorg. Med. Chem., 26, 2788, 10.1016/j.bmc.2017.09.040 · DOI
  106. Peschel, 2006, The co-evolution of host cationic antimicrobial peptides and microbial resistance, Nat. Rev. Microbiol., 4, 529, 10.1038/nrmicro1441 · DOI · Paper page
  107. Wang, 2001, Expanding the genetic code of Escherichia coli, Science, 292, 498, 10.1126/science.1060077 · DOI · Paper page
  108. Wang, 2004, Expanding the genetic code, Angew. Chem., Int. Ed. Engl., 44, 34, 10.1002/anie.200460627 · DOI · Paper page
  109. Oller-Salvia, 2019, Efficient phage display with multiple distinct noncanonical amino acids using orthogonal ribosome-mediated genetic code expansion, Angew. Chem., Int. Ed. Engl., 131, 10960, 10.1002/ange.201902658 · DOI
  110. Wang, 2017, Engineering the genetic code in cells and animals: biological considerations and impacts, Acc. Chem. Res., 50, 2767, 10.1021/acs.accounts.7b00376 · DOI
  111. Wang, 2001, Expanding the genetic code of Escherichia coli, Science, 292, 498, 10.1126/science.1060077 · DOI · Paper page
  112. Santoro, 2002, An efficient system for the evolution of aminoacyl-tRNA synthetase specificity, Nat. Biotechnol., 20, 1044, 10.1038/nbt742 · DOI · Paper page
  113. Anderson, 2004, An expanded genetic code with a functional quadruplet codon, Proc. Natl. Acad. Sci. U.S.A., 101, 7566, 10.1073/pnas.0401517101 · DOI · Paper page
  114. Niu, 2013, An expanded genetic code in mammalian cells with a functional quadruplet codon, ACS Chem. Biol., 8, 1640, 10.1021/cb4001662 · DOI
  115. Valentini, 2020, Bioorthogonal non-canonical amino acid tagging reveals translationally active subpopulations of the cystic fibrosis lung microbiota, Nat. Commun., 11, 2287, 10.1038/s41467-020-16163-2 · DOI
  116. Ernst, 2016, Genetic code expansion in the mouse brain, Nat. Chem. Biol., 12, 776, 10.1038/nchembio.2160 · DOI
  117. Liu, 2017, Genetic code expansion in zebrafish embryos and its application to optical control of cell signalling, J. Am. Chem. Soc., 139, 9100, 10.1021/jacs.7b02145 · DOI
  118. Brown, 2018, Genetic code expansion in animals, ACS Chem. Biol., 13, 2375, 10.1021/acschembio.8b00520 · DOI
  119. Wang, 2014, Construction of a live-attenuated HIV-1 vaccine through genetic code expansion, Angew. Chem., 126, 4967, 10.1002/ange.201402092 · DOI
  120. Si, 2016, Generation of influenza A viruses as live but replication-incompetent virus vaccines, Science, 354, 1170, 10.1126/science.aah5869 · DOI · Paper page
  121. Y. Zheng, et al., Broadening the versatility of lentiviral vectors as a tool in nucleic acid research via genetic code expansion, Nucleic Acids Res. 43(11), e73, https://doi.org/10.1093/nar/gkv202. · DOI
  122. Krauskopf, 2020, Increasing the chemical space of proteins in living cells via genetic code expansion, Curr. Opin. Chem. Biol., 58, 112, 10.1016/j.cbpa.2020.07.012 · DOI
  123. Drienovska, 2020, Expanding the enzyme universe with genetically encoded unnatural amino acids, Nat. Catal., 3, 193, 10.1038/s41929-019-0410-8 · DOI · Paper page
  124. Das, 2014, Identifying functionally important cis-peptide containing segments in proteins and their utility in molecular function annotation, FEBS J, 281, 5602, 10.1111/febs.13100 · DOI
  125. Lu, 2007, Prolyl cistransisomerization as a molecular timer, Nat. Chem. Biol., 3, 619, 10.1038/nchembio.2007.35 · DOI · Paper page
  126. Räder, 2018, Improving oral bioavailability of cyclic peptides by N-methylation, Bioorg. Med. Chem., 26, 2766, 10.1016/j.bmc.2017.08.031 · DOI · Paper page
  127. Teixeira, 2020, Nanomedicines for the delivery of antimicrobial peptides (AMPs), Nanomaterials, 10, 560, 10.3390/nano10030560 · DOI · Paper page
  128. Manniello, 2021, Insect antimicrobial peptides: potential weapons to counteract the antibiotic resistance, Cell. Mol. Life Sci., 78, 4259, 10.1007/s00018-021-03784-z · DOI · Paper page
  129. Lai, 2022, Strategies employed in the design of antimicrobial peptides with enhanced proteolytic stability, Biotechnol. Adv., 59, 107962, 10.1016/j.biotechadv.2022.107962 · DOI · Paper page
  130. Raj, 2021, Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy, Semin. Cancer Biol., 69, 166, 10.1016/j.semcancer.2019.11.002 · DOI · Paper page
  131. van Gent, 2021, Current advances in lipid and polymeric antimicrobial peptide delivery systems and coatings for the prevention and treatment of bacterial infections, Pharmaceutics, 13, 1840, 10.3390/pharmaceutics13111840 · DOI
  132. Thapa, 2020, Topical antimicrobial peptide formulations for wound healing: current developments and future prospects, Acta Biomater, 103, 52, 10.1016/j.actbio.2019.12.025 · DOI · Paper page
  133. Yao, 2018, Metabolism of peptide drugs and strategies to improve their metabolic stability, Curr. Drug Metabol., 19, 892, 10.2174/1389200219666180628171531 · doi:10.2174/1389200219666180628171531
  134. Wang, 2021, Antimicrobial peptides towards clinical application: delivery and formulation, Adv. Drug Deliv. Rev., 175, 113818, 10.1016/j.addr.2021.05.028 · DOI · Paper page
  135. Gan, 2021, The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions, Chem. Soc. Rev., 50, 7820, 10.1039/D0CS00729C · DOI · Paper page
  136. Gill, 2015, Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens, Chem. Biol. Drug Des., 85, 56, 10.1111/cbdd.12478 · DOI · Paper page
  137. Chen, 2022, Antimicrobial peptides: sustainable application informed by evolutionary constraints, Biotechnol. Adv., 60, 108012, 10.1016/j.biotechadv.2022.108012 · DOI
  138. Jiang, 2020, Targeting biofilms therapy: current research strategies and development hurdles, Microorganisms, 8, 1222, 10.3390/microorganisms8081222 · DOI · Paper page
  139. Dosler, 2013, In vitro pharmacokinetics of antimicrobial cationic peptides alone and in combination with antibiotics against methicillin resistant Staphylococcus aureus biofilms, Peptides, 49, 53, 10.1016/j.peptides.2013.08.008 · DOI
  140. Kumar, 2019, Aurein-derived antimicrobial peptides formulated with pegylated phospholipid micelles to target methicillin-resistant Staphylococcus aureus skin infections, ACS Infect. Dis., 5, 443, 10.1021/acsinfecdis.8b00319 · DOI
  141. Ma, 2017, Membrane-active amphipathic peptide WRL3 with in vitro antibiofilm capability and in vivo efficacy in treating methicillin-resistant Staphylococcus aureus burn wound infections, ACS Infect. Dis., 3, 820, 10.1021/acsinfecdis.7b00100 · DOI
  142. Menousek, 2012, Database screening and in vivo efficacy of antimicrobial peptides against methicillin-resistant Staphylococcus aureus USA300, Int. J. Antimicrob. Agents, 39, 402, 10.1016/j.ijantimicag.2012.02.003 · DOI
  143. M.F. Mohamed, A. Abdelkhalek, M. Seleem, Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular Staphylococcus aureus, Sci. Rep. 6 (1) (2016) 29707, https://doi.org/10.1038/srep29707. · DOI · Paper page
  144. Mohamed, 2014, Targeting methicillin-resistant Staphylococcus aureus with short salt-resistant synthetic peptides, Antimicrob. Agents Chemother., 58, 4113, 10.1128/AAC.02578-14 · DOI
  145. Mohamed, 1979, Efficacy of short novel antimicrobial and anti-inflammatory peptides in a mouse model of methicillin-resistant Staphylococcus aureus (MRSA) skin infection, Drug Des. Dev. Ther.
  146. Kumar, 2018, Aurein-derived antimicrobial peptides formulated with pegylated phospholipid micelles to target methicillin-resistant Staphylococcus aureus skin infections, ACS Infect. Dis., 5, 443, 10.1021/acsinfecdis.8b00319 · DOI
  147. Sierra, 2017, An overview of antimicrobial peptides and the latest advances in their development, Expet Opin. Biol. Ther., 17, 663, 10.1080/14712598.2017.1315402 · DOI · Paper page
  148. Wang, 2022, Therapeutic peptides: current applications and future directions, Signal Transduct. Targeted Ther., 7, 48, 10.1038/s41392-022-00904-4 · DOI · Paper page
  149. Chow, 2019, Ligation technologies for the synthesis of cyclic peptides, Chem. Rev., 119, 9971, 10.1021/acs.chemrev.8b00657 · DOI · Paper page
  150. Barman, 2023, Strategic approaches to improvise peptide drugs as next generation therapeutics, Int. J. Pept. Res. Therapeut., 29, 61, 10.1007/s10989-023-10524-3 · DOI

Cited by

See all 28

Metadata

Authors
Odunitan, T. T., Oyaronbi, A. O., Adebayo, F. A., Adekoyeni, P. A., Apanisile, B. T., Oladunni, T. D., & Saibu, O. A.
Venue
Pharmaceutical Science Advances
Publisher
Elsevier BV
Published
2024-12
Volume
2
Pages
100034
ISSN
2773-2169
Cited by
28
References
11
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antimicrobial peptides: A novel and promising arsenal against methicillin-resistant Staphylococcus aureus (MRSA) infections. https://app.cochat.ai/papers/10.1016/j.pscia.2023.100034
The paper
Odunitan, T. T., Oyaronbi, A. O., Adebayo, F. A., Adekoyeni, P. A., Apanisile, B. T., Oladunni, T. D., & Saibu, O. A. (2024). Antimicrobial peptides: A novel and promising arsenal against methicillin-resistant Staphylococcus aureus (MRSA) infections. Pharmaceutical Science Advances. https://doi.org/10.1016/j.pscia.2023.100034

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.